Delivery Order SPE2DB20D7061-SPE2DB25FSLK1

Award Date 11/26/24
Potential Completion Date 11/27/24
Potential Value $6.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,655.04 firm fixed price delivery order is for the supply of 4568745468 ! JUNEL 1 MG-20 MCG TABLET 21S, with a final completion date of July 11, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The current Delivery Order, valued at $4,402.80, is for the supply of 4559592833 - Junel FE 1.5 mg-30 mcg tablets, with a completion date of January 13, 2023. This IDC serves as a primary vehicle for Amerisourcebergen to provide a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,285.66 firm fixed price delivery order contract is for the supply of the contraceptive drug Junel FE 1 mg-20 mcg tablets. The contract has an ultimate completion date of August 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,657.35 firm fixed-price delivery order is for the supply of the drug Junel FE 1.5 mg-30 mcg tablets, with an ultimate completion date of October 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,326.42, is a delivery order for the pharmaceutical product JUNEL FE 1.5 MG-30 MCG TABLET 28S. The award does not have a set-aside designation, indicating an open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,148.34 fixed-price delivery order is for the pharmaceutical product "JUNEL FE 1.5 MG-30 MCG TABLET 28S", with a period of performance through November 2023. Amerisourcebergen is a large pharmaceutical distributor and healthcare solutions provider that maintains significant Indefinite Delivery Contracts (IDCs) with the DLA, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,070.96 firm fixed-price delivery order is for Junel FE 1 mg-20 mcg tablets, a generic contraceptive medication. The contract has an ultimate completion date of June 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,142.76, is a delivery order for the medical product "JUNEL FE 1 MG-20 MCG TABLET 28S". The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at up to $10,106.82, is for the delivery of the drug product Junel FE 1 mg-20 mcg tablet in 28-count packages. This is a firm fixed-price delivery order type contract with a completion date of September 26, 2024. Amerisourcebergen is providing these pharmaceutical products to support federal healthcare...
This federal contract award, valued at $111,908.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
  • SPE2DB20D7061
    Indefinite Delivery Contract
  • SPE2DB20D7061-SPE2DB25FSLK1
    Delivery Order

This federal contract award, valued at $6,312.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4566546039 JUNEL 1.5 MG-30 MCG TABLET 21S, with a completion date of November 27, 2024. The contract is a Firm Fixed Price agreement, with no set-aside designation.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/25/25, 10:07 AM